Patent-family-84547227
Applicants:
- University of Copenhagen [NORA names: KU University of Copenhagen; University; Denmark; Europe, EU; Nordic; OECD]
Abstract
The present disclosure relates novel cyclic peptides which can act as inhibitors of protein-protein interactions, specifically by inhibiting the PDZ2 domain of PSD-95, for use in treatment of excitotoxicity-related diseases and neuropathic pain.
Patent Family Records (1)
NOVEL CYCLIC PEPTIDE INHIBITORS OF PSD-95
UNIV OF COPENHAGEN, University of Copenhagen ALEXOPOULOU FLORA, Hink, Fabian, Rogers, Joseph M, (...more)
2024, WO-2024133413-A1